PreprintAll rights reservedbioRxiv
Targeting ALCAT1 Ameliorates Cardiomyopathy in Barth Syndrome
- 1The University of Texas Health Science Center at San Antonio
Related
- CAR-macrophage immunotherapy targeting fibroblast-like synoviocytes ameliorates inflammatory and degenerative arthritis
- Dendrimer Delivered shRNA Targeting the CCL20-CCR6 Axis Suppresses Complement-Mediated Microglial Synaptic Pruning and Ameliorates Chronic Neuroinflammation After Repetitive Traumatic Brain Injury
- Isoquercitrin ameliorates chondrocyte dysfunction in osteoarthritis by targeting AKT1-mediated mitochondrial dynamics regulation
- Targeting the CD74-MHC II axis with allergen-specific immunotherapy ameliorates pollen-induced allergic asthma.
- Emodin induces defensive autophagy against white spot syndrome virus infection via targeting the hemocyanin-mediated endoplasmic reticulum-mitochondrial crosstalk in shrimp
BibTeX
@misc{zhang2026targeting,
title = {{Targeting ALCAT1 Ameliorates Cardiomyopathy in Barth Syndrome}},
author = {J. Zhang and Q. Ye and X. Fang and W. Huang and Y. Shi},
howpublished = {bioRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.24.754267},
url = {https://www.biorxiv.org/content/10.64898/2026.09.24.754267v1},
}
RIS
TY - UNPB
TI - Targeting ALCAT1 Ameliorates Cardiomyopathy in Barth Syndrome
AU - J. Zhang
AU - Q. Ye
AU - X. Fang
AU - W. Huang
AU - Y. Shi
PY - 2026
DA - 2026/09/24
PB - bioRxiv
DO - 10.64898/2026.09.24.754267
UR - https://www.biorxiv.org/content/10.64898/2026.09.24.754267v1
ER -